menu
    • menu

    Company profile for Icosavax

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are committed to developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. We were founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. By utilizing computationally designed prot...
    We are committed to developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. We were founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. By utilizing computationally designed proteins that self-assemble into virus-like particles (VLPs), we are able to readily manufacture VLPs displaying complex antigens to target significant unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IcosavaxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2815 Eastlake Ave E, Suite 300 Seattle, WA 98102
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://icosavax.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/icosavax
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca completes acquisition of Icosavax
    AstraZeneca completes acquisition of Icosavax

    21 Feb 2024

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/astrazeneca-completes-acquisition-of-icosavax-15295

    INDIAN PHARMA POST
    21 Feb 2024
    Share Share
    AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
    AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase

    13 Dec 2023

    // BIOSPACE

    https://www.biospace.com/article/astrazeneca-buys-into-rsv-vaccine-market-with-potential-1-1b-icosavax-purchase/

    BIOSPACE
    13 Dec 2023
    Share Share
    Icosavax Announces Positive Topline Interim Phase 2 Results for IVX-A12
    Icosavax Announces Positive Topline Interim Phase 2 Results for IVX-A12

    12 Dec 2023

    // PRESS RELEASE

    https://investors.icosavax.com/news-releases/news-release-details/icosavax-announces-positive-topline-interim-phase-2-results

    PRESS RELEASE
    12 Dec 2023
    Share Share
    Icosavax Reports Third Quarter 2023 Financial Results
    Icosavax Reports Third Quarter 2023 Financial Results

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2780510/0/en/Icosavax-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    Icosavax to Participate in the Jefferies London Healthcare Conference
    Icosavax to Participate in the Jefferies London Healthcare Conference

    08 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/08/2776171/0/en/Icosavax-to-Participate-in-the-Jefferies-London-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Nov 2023
    Share Share
    Icosavax to Participate in Guggenheim Healthcare Talks 5th Annual INI Conference
    Icosavax to Participate in Guggenheim Healthcare Talks 5th Annual INI Conference

    31 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/31/2770090/0/en/Icosavax-to-Participate-in-the-Guggenheim-Healthcare-Talks-5th-Annual-Inflammation-Neurology-Immunology-INI-Conference.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search